Using biological materials to repair bone defects around teeth
Official title: Evaluation of the Addition of Different Biologicals in the Surgical Treatment of Periodontal Intra-Bony Defects: A Randomised Controlled Clinical Trial.
Run by Universitaire Ziekenhuizen KU Leuven · NCT07292870 · Data updated 2026-11-12
This study will test whether enamel matrix, hyaluronic acid, platelet‑rich fibrin, or a bone graft can help repair intra‑bony defects around teeth in adults with periodontitis who need minimally invasive gum surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Universitaire Ziekenhuizen KU Leuven Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Leuven, Vlaams Brabant) |
| Status | Recruiting |
| Started | August 8, 2025 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | March 17, 2026 |
| Trial ID | NCT07292870 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with periodontitis who have completed non‑surgical therapy and have non‑contained (2‑wall) intra‑bony defects of ≥6 mm who are medically fit for minimally invasive periodontal surgery (ASA I–II) are ideal candidates.
✕Probably not a fit
People under 18, those with medical conditions that would jeopardize safety or protocol compliance, those with prior or concurrent treatments that compromise outcomes, or those without the specified 2‑wall defects are unlikely to benefit from enrollment.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults who meet entry criteria undergo minimally invasive surgical access to clean the intra‑bony defect and are then randomly assigned to receive one of four biomaterial approaches: xenograft (Bio‑Oss® Collagen) plus enamel matrix derivative (Emdogain®), xenograft plus hyaluronic acid (REGENFAST®), xenograft plus L‑PRF (leukocyte and platelet rich fibrin), or L‑PRF alone. The trial uses a non‑inferiority design to test whether hyaluronic acid or L‑PRF achieve at least the same clinical attachment level (CAL) gains as the enamel matrix derivative. Outcomes include changes in CAL and probing pocket depth (PPD) at 6 and 12 months, volumetric soft‑tissue (papilla) preservation by intra‑oral scan, and radiographic measures of defect resolution and bone fill. Procedures are performed at a single academic dental center with standard perioperative care and follow‑up visits at 6 and 12 months.
Why it matters
Potential benefit: If successful, the alternatives could provide equally effective and potentially simpler or more accessible biological options to the current enamel matrix standard for repairing periodontal bone defects.
How similar studies have gone: Enamel matrix derivatives are an established treatment and smaller studies support benefits from platelet concentrates and hyaluronic acid, but direct head‑to‑head non‑inferiority comparisons remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures * At least 18 years of age at the time of signing the Informed Consent Form (ICF) * American Society of Anesthesiology (ASA) score I or II * Has already completed the non-surgical periodontal therapy with remaining local pockets of ≥ 6 mm14 * The intra-bony defect should be non-contained (2-wall defect) * Clinical indication for surgical treatment of the intra-bony defect with minimally invasive approach in conjunction with biologicals Exclusion Criteria: * Under the age of 18 years * Any disorder, which in the Investigator's opinion might jeopardise the participant's safety or compliance with the protocol * Any prior or concomitant treatment(s) that might jeopardise the participant's safety or that would compromise the integrity of the Trial * Participation in an interventional Trial with an investigational medicinal product (IMP) or device * Known or suspected current malignancy * History of chemotherapy * History of radiation in the head and neck region * History of other metabolic bone diseases * Current or previous use of intravenous and oral bisphosphonates * Haematological disorders * Pregnancy / lactation * Smoking
Where it's running
-
UZLeuven, Campus St. Raphaël, Department Oral Health Sciences, Periodontology
Leuven, Vlaams Brabant, Belgium Recruiting
Study contacts
- Principal investigator: Ana Castro, Professor — UZLeuven, department of Oral Health Sciences, Periodontology
- Study coordinator: Ana B Castro Sarda, Professor
- Email: ana.castro@uzleuven.be
- Phone: +32 16 332816
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Association Between Periodontitis and Dry Eye Disease in Adults
This study tests whether periodontitis and dry eye disease are linked by comparing groups with and without each condition.
-
Periodontal Infection and Inflammatory Markers in Missed Abortion
Researchers will test whether gum infection and inflammation are linked to missed abortion in pregnant women with no major chromosomal problems.
-
Smoking, MFN1, and NLRP3 Levels in Gum Fluid Across Periodontal Health and Disease
This study tests whether smoking changes MFN1 and NLRP3 protein levels in the fluid around the gums for adults with or without periodontitis.
-
Dental Loupes vs. Dental Operating Microscope for Non-Surgical Periodontal Treatment
This study tests whether using dental loupes or a dental operating microscope makes non-surgical periodontal cleaning more effective for adults with periodontitis.
-
Boron, Oxidative Stress, and Inflammation in Periodontitis
This observational study compares boron levels and inflammation markers in saliva and gum tissue between people with periodontitis and healthy controls to see if boron relates to gum inflammation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.